Sept 12 (Reuters) - Pfizer Inc's trial data on
Chantix, a drug to help people quit smoking, failed to impress
U.S. Food and Drug Administration scientists, in a blow to the
company's attempts to have a serious warning removed from the
drug's label.
Read more
No comments:
Post a Comment